Fig. 1From: Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trialEnrollment and Analysis Inclusion by Antepartum Period, Hepatitis B Surface Antigen Status, and Randomization Arm. HBsAg Hepatitis B Surface Antigen, ZDV zidovudine, TDF tenofovir disoproxil fumarate, ART antiretroviral therapyBack to article page